Visteon Q1 sales rise 2% to $954 million; profit falls, guidance reaffirmed
Visteon reported first-quarter 2026 sales of $954 million, up 2% from $934 million a year earlier, while net income attributable to Visteon fell to $31 million from $67 million. The company reaffirmed its full-year 2026 guidance for sales, adjusted EBITDA and adjusted free cash flow, so shareholders see stronger revenue but lower profit with no change to the outlook.
Key points
- Net sales were $954 million versus $934 million a year earlier, up 2%.
- Diluted EPS was $1.14, down from $2.44; adjusted EBITDA was $104 million, down from $129 million.
- Full-year 2026 guidance was reaffirmed: sales of $3.625 billion to $3.825 billion and adjusted EBITDA of $455 million to $495 million.
- The company returned $40 million to shareholders in the quarter through $30 million of share repurchases and $10 million of dividends.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 23, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.